✦ LIBER ✦

Remission rate and survival in acute myeloid leukemia: Impact of selection and chemotherapy

✍ Scribed by Anders Wahlin; Per Hörnsten; Håkan Jonsson

Book ID: 114791444
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 721 KB
Volume: 46
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1991.tb00547.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of remission induction chemothera

Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia

✍ Rachid Baz; Cristina Rodriguez; Alex Z. Fu; Rony Abou Jawde; Matt Kalaycio; Anja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## BACKGROUND. Significant controversy surrounds the use of remission induction chemotherapy (IC) in older adults with acute myeloid leukemia (AML). Earlier clinical trials have yielded conflicting results and possibly a minor survival benefit, often offset by a longer hospitalization

Day 14 bone marrow biopsy in predicting

Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia

✍ Kebede Hussein; Balkrishna Jahagirdar; Pankaj Gupta; Linda Burns; Karen Larsen; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Invasive fungal diseases during first in

Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia

✍ Girmenia, Corrado; Micozzi, Alessandra; Piciocchi, Alfonso; Gentile, Giuseppe; D 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 587 KB

Duration of first remission predicts rem

Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia

✍ Stahnke, K; Boos, J; Bender-Götze, C; Ritter, J; Zimmermann, M; Creutzig, U 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Remission with high erythrocyte sediment

Remission with high erythrocyte sedimentation rates in acute myeloid leukemia is of short duration

✍ Brizzi, A. ;Ogier, C. ;Reizenstein, P. 📂 Article 📅 1985 🏛 Springer-Verlag ⚖ 80 KB

Selective use of daunorubicin for remiss

Selective use of daunorubicin for remission-induction chemotherapy in acute non-lymphoblastic leukemia

✍ B. S. Shaikh; J. B. Dougherty; R. W. Hamilton; J. O. Ballard; S. B. Patel; N. R. 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 2 views

Twenty-eight patients with acute non-lymphoblastic leukemia (ANLL) were started on induction chemotherapy consisting of Cytosine Arbinoside (Ara C) and 6 thioguanine (TG). Daunoruhicin (DNR) was used selectively in 20 of 28 patients who failed to respond by day 14 to the Ara C and TG combination. Se